💊Antidepressants and the Heart: What New Research Reveals About Sudden Cardiac Death Risk

Depression is one of the leading health challenges worldwide, affecting an estimated 300 million people globally, according to the World Health Organization (WHO). For many, antidepressants are not only life-improving but life-saving, offering relief from persistent sadness, anxiety, and suicidal thoughts. These medications have been widely prescribed for decades, forming a cornerstone of mental health care.

But as their use has expanded—often for long-term treatment—a critical question is being raised: what are the long-term effects of antidepressants on the heart?

At the 2025 European Heart Rhythm Association (EHRA) Congress, researchers presented a study that sheds new light on this issue. The findings suggest that people who remain on antidepressants for several years may face an increased risk of sudden cardiac death, a condition where the heart unexpectedly stops beating.

The implications are profound. While antidepressants remain vital tools for managing mental illness, this research underscores the need to carefully balance their mental health benefits with potential physical health risks.

Understanding Sudden Cardiac Death

Sudden cardiac death (SCD) occurs when the heart suddenly and unexpectedly stops pumping blood. Unlike a typical heart attack, which results from blocked arteries, SCD often stems from abnormal heart rhythms (arrhythmias) that disrupt the heart’s electrical system.

• In adults, SCD is responsible for nearly 15–20% of all deaths in industrialized countries.
• The condition can strike without warning, sometimes in otherwise healthy individuals.
• Risk factors include structural heart disease, inherited arrhythmias, lifestyle factors, and—increasingly recognized—medication side effects.

The Study at a Glance

The new research analyzed death records from Denmark in 2010, focusing on individuals prescribed antidepressants. Key findings included:

• Long-term use (6+ years): Patients faced a 2.2 times higher risk of sudden cardiac death compared to those who had never taken antidepressants.
• Young adults (ages 30–39): The risk was particularly striking in this group—five times higher compared to non-users.
• Short-to-medium use (1–5 years): Even those on antidepressants for less than six years had a 56% increased risk of sudden cardiac death.

Importantly, the study did not specify which types of antidepressants carried the greatest risk, but the association with duration of use raises concerns about cumulative effects on heart health.

Why Might Antidepressants Raise Heart Risks?

Antidepressants are diverse, including SSRIs (selective serotonin reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake inhibitors), TCAs (tricyclic antidepressants), and MAOIs (monoamine oxidase inhibitors). Each class works differently in the brain, but many also affect the cardiovascular system.

Possible mechanisms include:

1. Heart rhythm changes (QT prolongation):
   Some antidepressants interfere with the heart’s electrical signaling, leading to prolonged QT intervals. This can trigger dangerous arrhythmias such as torsades de pointes, which may progress to cardiac arrest.

2. Blood pressure effects:
   Certain antidepressants, particularly SNRIs and TCAs, can raise blood pressure or cause fluctuations that stress the cardiovascular system.

3. Weight gain and metabolic changes:
   Long-term antidepressant use has been linked to weight gain, diabetes, and metabolic syndrome—all major contributors to cardiovascular disease.

4. Depression itself as a risk factor:
   Even without medication, depression increases the risk of heart disease through inflammation, altered stress hormones (like cortisol), and unhealthy coping behaviors such as smoking or physical inactivity.

Case Study 1: A Young Adult on Long-Term Therapy

Michael, a 32-year-old IT professional, began taking antidepressants in his early twenties to manage severe depression. Over the years, his symptoms improved, but he noticed gradual weight gain and rising blood pressure. After learning about the study, he consulted his doctor, who recommended an ECG to monitor heart rhythm and lifestyle interventions like exercise and diet modifications. Michael’s case illustrates the need for proactive cardiac monitoring, especially in younger patients who may remain on medication for decades.

Case Study 2: An Older Patient with Multiple Risks

Helen, a 58-year-old teacher, had been on antidepressants for over 10 years. She also had type 2 diabetes and hypertension. While the antidepressants kept her mood stable, her physician raised concerns about her cumulative cardiac risks. A cardiology referral confirmed mild QT prolongation. Instead of discontinuing her antidepressants abruptly, her care team adopted a multidisciplinary approach, adjusting her medication, optimizing diabetes control, and scheduling regular heart rhythm checks.

Antidepressants vs. Untreated Depression: A Delicate Balance

It’s crucial to stress that the study does not advocate stopping antidepressants. Untreated depression itself can be deadly—linked not only to suicide but also to higher risks of heart attack and stroke.

The goal, therefore, is not to demonize antidepressants but to individualize treatment:

• For some patients, antidepressants may carry more benefits than risks.
• For others, particularly those with existing cardiovascular risks, a combination of therapy, lifestyle changes, and cautious medication use may be safer.

What Experts Recommend

1. Cardiac monitoring: Patients on long-term antidepressants—especially beyond five years—should undergo regular ECGs to detect rhythm abnormalities early.
2. Risk stratification: Doctors should consider cardiovascular history before prescribing antidepressants, particularly for young adults and patients with metabolic risks.
3. Lifestyle interventions: Exercise, balanced nutrition, smoking cessation, and stress reduction can buffer both depression and heart disease risks.
4. Open dialogue: Patients should not stop medication on their own but should feel empowered to discuss cardiac safety with their healthcare providers.
5. Research expansion: Future studies should clarify which antidepressant classes pose the highest risks, helping clinicians make more informed choices.

Global Trends and the Bigger Picture

Antidepressant use is rising rapidly worldwide:

• In the United States, nearly 1 in 8 adults takes an antidepressant, with usage nearly doubling over the last two decades.
• In Europe, long-term antidepressant prescriptions are increasingly common, particularly among young adults and middle-aged women.
• The COVID-19 pandemic accelerated reliance on these medications, as global rates of depression and anxiety surged.

As treatment durations extend, the population at risk of long-term cardiac side effects is likely to grow. This makes the Danish findings especially relevant for public health policy and preventive cardiology.

Conclusion

Antidepressants remain an essential part of modern mental health care, offering hope and stability to millions. Yet, the Danish study presented at the 2025 EHRA Congress reminds us that no medication is without risks. Long-term antidepressant use—especially beyond six years—may increase the likelihood of sudden cardiac death, with the effect most pronounced in younger adults.

This does not mean patients should abandon treatment. Instead, it highlights the importance of integrated care: monitoring heart health alongside mental health, tailoring treatment to individual risk profiles, and ensuring open communication between patients and providers.

Ultimately, the goal is balance—preserving the life-saving benefits of antidepressants while safeguarding the heart. As science advances, one message is clear: treating the mind and protecting the heart must go hand in hand.